Cart
sales@molnova.com
NVP-ADW742 b
CAS No. 475488-23-4
NVP-ADW742 b ( ADW;GSK 552602A;ADW742 )
Catalog No. M19445 CAS No. 475488-23-4
NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM >16-fold more potent against IGF-1R than InsR; little activity to HER2 PDGFR VEGFR-2 Bcr-Abl and c-Kit.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 96 | In Stock |
|
| 10MG | 160 | In Stock |
|
| 25MG | 289 | In Stock |
|
| 50MG | 532 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNVP-ADW742 b
-
NoteResearch use only not for human use.
-
Brief DescriptionNVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM >16-fold more potent against IGF-1R than InsR; little activity to HER2 PDGFR VEGFR-2 Bcr-Abl and c-Kit.
-
DescriptionNVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM >16-fold more potent against IGF-1R than InsR; little activity to HER2 PDGFR VEGFR-2 Bcr-Abl and c-Kit.
-
SynonymsADW;GSK 552602A;ADW742
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorIGF-1R
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number475488-23-4
-
Formula Weight453.58
-
Molecular FormulaC28H31N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mg/mL (22.04 mM) warmed;Ethanol:3 mg/mL (6.61 mM);Water:<1 mg/mL
-
SMILESC1CCN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6
-
Chemical Name5-(3-(benzyloxy)phenyl)-7-((1r3r)-3-(pyrrolidin-1-ylmethyl)cyclobutyl)-7H-pyrrolo[23-d]pyrimidin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mitsiades CS et al. Cancer Cell 2004 5(3) 221-230.
molnova catalog
related products
-
IGF-I 24-41
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
PQ401 hydrochloride
PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
-
Linsitinib
Linsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively.
